Soluble glycoprotein VI predicts abdominal aortic aneurysm growth rate and is a novel therapeutic target
- 17 October 2024
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 144 (16) , 1663-1678
Abstract
A common feature in patients with abdominal aortic aneurysms (AAAs) is the formation of a nonocclusive intraluminal thrombus (ILT) in regions of aortic dilation. Platelets are known to maintain hemostasis and propagate thrombosis through several redundant activation mechanisms, yet the role of platelet activation in the pathogenesis of AAA-associated ILT is still poorly understood. Thus, we sought to investigate how platelet activation affects the pathogenesis of AAA. Using RNA sequencing, we identified that the platelet-associated transcripts are significantly enriched in the ILT compared with the adjacent aneurysm wall and healthy control aortas. We found that the platelet-specific receptor glycoprotein VI (GPVI) is among the top enriched genes in AAA ILT and is increased on the platelet surface of patients with AAAs. Examination of a specific indicator of platelet activity, soluble GPVI (sGPVI), in 2 independent cohorts of patients with AAAs is highly predictive of an AAA diagnosis and associates more strongly with aneurysm growth rate than D-dimer in humans. Finally, intervention with the anti-GPVI antibody (JAQ1) in mice with established aneurysms blunted the progression of AAA in 2 independent mouse models. In conclusion, we show that the levels of sGPVI in humans can predict a diagnosis of AAA and AAA growth rate, which may be critical in the identification of high-risk patients. We also identify GPVI as a novel platelet-specific AAA therapeutic target, with minimal risk of adverse bleeding complications, for which none currently exists.Keywords
This publication has 74 references indexed in Scilit:
- Efficacy and Safety of Revacept, a Novel Lesion-Directed Competitive Antagonist to Platelet Glycoprotein VI, in Patients Undergoing Elective Percutaneous Coronary Intervention for Stable Ischemic Heart DiseaseJAMA Cardiology, 2021
- Population Pharmacokinetic/Pharmacodynamic Modeling of Glenzocimab (ACT017) a Glycoprotein VI Inhibitor of Collagen‐Induced Platelet AggregationThe Journal of Clinical Pharmacology, 2020
- Collagen fibril abnormalities in human and mice abdominal aortic aneurysmActa Biomaterialia, 2020
- Evaluation of the distribution and progression of intraluminal thrombus in abdominal aortic aneurysms using high‐resolution MRIJournal of Magnetic Resonance Imaging, 2019
- Proteolytic processing of platelet receptorsResearch and Practice in Thrombosis and Haemostasis, 2018
- Activation of HuR downstream of p38 MAPK promotes cardiomyocyte hypertrophyCellular Signalling, 2016
- D-dimer2015
- Comparative Safety of Endovascular Aortic Aneurysm Repair Over Open Repair Using Patient Safety Indicators During AdoptionJAMA Surgery, 2014
- Prolonged Infusion of Angiotensin II in apoE−/− Mice Promotes Macrophage Recruitment with Continued Expansion of Abdominal Aortic AneurysmThe American Journal of Pathology, 2011
- Contribution of platelet glycoprotein VI to the thrombogenic effect of collagens in fibrous atherosclerotic lesionsAtherosclerosis, 2005